日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alterations in the CTRB2 gene and response to chemotherapy in pancreatic cancer

CTRB2基因改变与胰腺癌化疗反应的关系

Jazieh, Khalid; Carlson, Erin E; Siddiqui, Zafar; Connelly, Katelyn E; Zhong, Jun; Hoskins, Jason W; Rabe, Kari G; Oberg, Ann L; Sicotte, Hugues; Carr, Ryan M; Amundadottir, Laufey T; Antwi, Samuel O

Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer.

Emerin 是胰腺癌中致癌 KRAS 驱动的核动力学的效应因子

Flores Luis F, Marks David L, Vera Renzo E, Sigafoos Ashley N, Tolosa Ezequiel J, Almada Luciana L, Pease David R, Toruner Merih D, Chang Brian, Tader Brooke R, LaRue-Nolan Kayla C, Carr Ryan M, Graham Rondell P, Hagen Catherine E, Brown Matthew R, Matveyenko Aleksey V, Wilson Katherine L, Dawson David W, Pin Christopher L, Roux Kyle J, Fernandez-Zapico Martin E

Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma

胰腺神经内分泌肿瘤与胰腺导管腺癌的风险因素不一致

Chandra, Shruti; Halfdanarson, Thorvardur R; Carlson, Erin E; Rabe, Kari G; Mahipal, Amit; Majumder, Shounak; Bamlet, William R; Horibe, Masayasu; Tella, Sri Harsha; Shariq, Omair; Carr, Ryan M; Cleary, Sean P; Oberg, Ann L; Antwi, Samuel O

Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study

分子KRAS ctDNA预测胰腺癌转移和生存:一项前瞻性队列研究

Leiting, Jennifer L; Alva-Ruiz, Roberto; Yonkus, Jennifer A; Abdelrahman, Amro M; Lynch, Isaac T; Carlson, Danielle M; Carr, Ryan M; Salomao, Diva R; McWilliams, Robert R; Starlinger, Patrick P; Thiels, Cornelius A; Grotz, Travis E; Warner, Susanne G; Cleary, Sean P; Kendrick, Michael L; Smoot, Rory L; Kipp, Benjamin R; Truty, Mark J

Lung adenocarcinomas without driver genes converge to common adaptive strategies through diverse genetic, epigenetic, and niche construction evolutionary pathways

不携带驱动基因的肺腺癌通过多种遗传、表观遗传和微环境构建的进化途径,趋向于共同的适应性策略。

Gatenby, Robert A; Luddy, Kimberly A; Teer, Jamie K; Berglund, Anders; Freischel, Audrey R; Carr, Ryan M; Lam, Amanda E; Pienta, Kenneth J; Amend, Sarah R; Austin, Robert H; Hammarlund, Emma U; Cleveland, John L; Tsai, Kenneth Y; Brown, Joel S

Correction: E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis

更正:E3泛素连接酶PARK2是黑色素瘤细胞生长的抑制因子,它受到致癌ERK1/2-ELK1转录轴的抑制。

Rosenau, Jana; Grothaus, Isabell Louise; Yang, Yikun; Kumar, Nilima Dinesh; Ciacchi, Lucio Colombi; Kelm, Sørge; Waespy, Mario; Olivier, Paul; Mast, Fred; Fridy, Peter; Ketaren, Natalia; Miller, Leslie; Sanyal, Tanmoy; Rout, Michael; Chait, Brian; Aitchison, John; Tobacman, Joanne; Bhattacharyya, Sumit; Gangopadhyay, Kaustav; Roy, Arnab; Chandradasan, Athira; Roy, Swarnendu; Debnath, Olivia; SenGupta, Soumee; Chowdhury, Subhakar; Das, Dipjyoti; Das, Rahul; Arvind, Ramanathan; Trifan, Anda; Ozgulbas, Defne; Brace, Alexander; Hippe, Kyle; Anandkumar, Anima; Harris, Sarah; Tajkhorshid, Emad; Stone, John; El Khoury, Marianne; Wanes, Dalanda; Lynch-Miller, Maura; Naim, Hassan; Montagnani, Valentina; Maresca, Luisa; Apollo, Alessandro; Pepe, Sara; Carr, Ryan M; Fernandez-Zapico, Martin E; Stecca, Barbara

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

水杨酸盐通过诱导 S 期阻滞和损害 DNA 损伤修复来增强 CRM1 抑制剂的抗肿瘤活性

Abeykoon Jithma P, Wu Xiaosheng, Nowakowski Kevin E, Dasari Surendra, Paludo Jonas, Weroha S John, Hu Chunling, Hou Xiaonan, Sarkaria Jann N, Mladek Ann C, Phillips Jessica L, Feldman Andrew L, Ravindran Aishwarya, King Rebecca L, Boysen Justin, Stenson Mary J, Carr Ryan M, Manske Michelle K, Molina Julian R, Kapoor Prashant, Parikh Sameer A, Kumar Shaji, Robinson Steven I, Yu Jia, Boughey Judy C, Wang Liewei, Goetz Matthew P, Couch Fergus J, Patnaik Mrinal M, Witzig Thomas E

Research on Anal Squamous Cell Carcinoma: Systemic Therapy Strategies for Anal Cancer

肛门鳞状细胞癌研究:肛门癌的系统治疗策略

Carr, Ryan M; Jin, Zhaohui; Hubbard, Joleen

Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia

骨髓树突状细胞聚集与慢性粒单核细胞白血病中的全身免疫失调有关

Mangaonkar, Abhishek A; Reichard, Kaaren K; Binder, Moritz; Coltro, Giacomo; Lasho, Terra L; Carr, Ryan M; Chiu, April; Negron, Vivian; Hefazi, Mehrdad; Anagnostou, Theodora; Timm, Michael M; Hiebert, James W; Villasboas, Jose C; Gonsalves, Wilson I; Gangat, Naseema; Shah, Mithun; Alkhateeb, Hassan B; Al-Kali, Aref; Elliott, Michelle A; Begna, Kebede H; Wolanskyj-Spinner, Alexandra P; Litzow, Mark R; Hogan, William J; Ansell, Stephen M; Pardanani, Animesh; Tefferi, Ayalew; Patnaik, Mrinal M

Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer

维莫德吉联合厄洛替尼治疗转移性胰腺癌的I期临床试验

McCleary-Wheeler, Angela L; Carr, Ryan M; Palmer, Shanique R; Smyrk, Thomas C; Allred, Jacob B; Almada, Luciana L; Tolosa, Ezequiel J; Lamberti, Maria J; Marks, David L; Borad, Mitesh J; Molina, Julian R; Qi, Yingwei; Lingle, Wilma L; Grothey, Axel; Pitot, Henry C; Jatoi, Aminah; Northfelt, Donald W; Bryce, Alan H; McWilliams, Robert R; Okuno, Scott H; Haluska, Paul; Kim, George P; Colon-Otero, Gerardo; Lowe, Val J; Callstrom, Matthew R; Ma, Wen We; Bekaii-Saab, Tanios; Hung, Mien-Chie; Erlichman, Charles; Fernandez-Zapico, Martin E